{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:12:03Z","timestamp":1788394323043,"version":"build-2803163510"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":1237,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T00:00:00Z","timestamp":1658016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"University College London Hospitals National Institute for Health Research"},{"name":"Biomedical Research Centre"},{"name":"Netherlands Organization for Sciences-ZonMW","award":["VICI 91818602"],"award-info":[{"award-number":["VICI 91818602"]}]},{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"crossref","award":["Dekker 2015T041"],"award-info":[{"award-number":["Dekker 2015T041"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"crossref","award":["CVON2014-40 DOSIS"],"award-info":[{"award-number":["CVON2014-40 DOSIS"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018890","name":"Dutch Cardiovascular Alliance","doi-asserted-by":"publisher","award":["2020B005 DOUBLE DOSE"],"award-info":[{"award-number":["2020B005 DOUBLE DOSE"]}],"id":[{"id":"10.13039\/100018890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018890","name":"Dutch Cardiovascular Alliance","doi-asserted-by":"publisher","award":["CVON2015-12 eDETECT"],"award-info":[{"award-number":["CVON2015-12 eDETECT"]}],"id":[{"id":"10.13039\/100018890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["VICI 91818602"],"award-info":[{"award-number":["VICI 91818602"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["CVON2014\u201040 DOSIS"],"award-info":[{"award-number":["CVON2014\u201040 DOSIS"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["2020B005 DOUBLE DOSE"],"award-info":[{"award-number":["2020B005 DOUBLE DOSE"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["CVON2015\u201012 eDETECT"],"award-info":[{"award-number":["CVON2015\u201012 eDETECT"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["Dekker 2015T041"],"award-info":[{"award-number":["Dekker 2015T041"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Hypertrophic cardiomyopathy (HCM) is the most prevalent monogenic heart disease. HCM is an important cause of sudden cardiac death and may also lead to outflow tract obstruction and heart failure. Disease severity is highly variable and risk stratification remains limited. Therefore, we aimed to review current knowledge of prognostic blood-based biomarkers in HCM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A systematic literature search was performed on PubMed, Embase, and the Cochrane library to identify studies assessing plasma or serum biomarkers for outcomes involving malignant ventricular arrhythmia, outflow tract obstruction, and heart failure. Risk of bias was assessed using the QUIPS tool. Meta-analyses were performed using the random effects method. A total of 26 unique cohort studies assessing 42 biomarkers were identified. Overall risk of bias was moderate. Thirty-two biomarkers were significantly associated to an HCM outcome in at least one study (nine biomarkers in at least two studies). In pooled analyses, cardiovascular mortality was predicted by N-terminal prohormone of brain natriuretic peptide (hazard ratio [HR] 5.38 per log[pg\/mL], 95% confidence interval [CI] 2.07\u201314.03, P &amp;lt; 0.001, I2 = 0%) and high-sensitivity C-reactive protein (HR 1.30 per \u03bcg\/mL, 95% CI 1.00\u20131.68, P = 0.05, I2 = 78%), all-cause mortality by low-density lipoprotein cholesterol (HR 0.63 per \u03bcmol\/mL, 95% CI 0.49\u20130.80, P &amp;lt; 0.001, I2 = 0%), and a combined congestive heart failure, malignant ventricular arrhythmia, and stroke outcome by high-sensitivity cardiac troponin T (pooled HR 4.19 for \u22650.014 ng\/mL, 95% CI 2.22\u20137.88, P &amp;lt; 0.001, I2 = 0%). Quality of evidence was low\u2013moderate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Several blood-based biomarkers were identified as predictors of HCM outcomes. Additional studies are required to validate their prognostic utility within current risk stratification models.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14073","type":"journal-article","created":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T08:04:55Z","timestamp":1658045095000},"page":"3418-3434","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Blood-Based Biomarkers for the Prediction of Hypertrophic Cardiomyopathy Prognosis: A Systematic Review and Meta-Analysis"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0896-4440","authenticated-orcid":false,"given":"Mark","family":"Jansen","sequence":"first","affiliation":[{"name":"Department of Genetics, University Medical Center Utrecht, Utrecht University , Utrecht ,","place":["The Netherlands"]},{"name":"Netherlands Heart Institute , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sila","family":"Alg\u00fcl","sequence":"additional","affiliation":[{"name":"Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Vrije Universiteit Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens P.","family":"Bosman","sequence":"additional","affiliation":[{"name":"Netherlands Heart Institute , Utrecht ,","place":["The Netherlands"]},{"name":"Department of Cardiology, University Medical Center Utrecht, Utrecht University , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Michels","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Erasmus University , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda","family":"van der Velden","sequence":"additional","affiliation":[{"name":"Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Vrije Universiteit Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Groningen, University of Groningen , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Peter","family":"van Tintelen","sequence":"additional","affiliation":[{"name":"Department of Genetics, University Medical Center Utrecht, Utrecht University , Utrecht ,","place":["The Netherlands"]},{"name":"Netherlands Heart Institute , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folkert W.","family":"Asselbergs","sequence":"additional","affiliation":[{"name":"Netherlands Heart Institute , Utrecht ,","place":["The Netherlands"]},{"name":"Department of Cardiology, University Medical Center Utrecht, Utrecht University , Utrecht ,","place":["The Netherlands"]},{"name":"Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London , London ,","place":["UK"]},{"name":"Health Data Research UK and Institute of Health Informatics, University College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette F.","family":"Baas","sequence":"additional","affiliation":[{"name":"Department of Genetics, University Medical Center Utrecht, Utrecht University , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,17]]},"reference":[{"key":"2026012114162367500_ehf214073-bib-0001","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"2026012114162367500_ehf214073-bib-0002","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026012114162367500_ehf214073-bib-0003","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026012114162367500_ehf214073-bib-0004","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.117.033427","article-title":"Prospective countywide surveillance and autopsy characterization of sudden cardiac death: POST SCD study","volume":"137","author":"Tseng","year":"2018","journal-title":"Circulation"},{"key":"2026012114162367500_ehf214073-bib-0005","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026012114162367500_ehf214073-bib-0006","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"2026012114162367500_ehf214073-bib-0007","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","article-title":"Enhanced American College of Cardiology\/American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy","volume":"4","author":"Maron","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026012114162367500_ehf214073-bib-0008","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"2026012114162367500_ehf214073-bib-0009","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ejhf.1494","article-title":"Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations","volume":"21","author":"Mueller","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012114162367500_ehf214073-bib-0010","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/cvr\/cvx183","article-title":"Cardiac troponins: from myocardial infarction to chronic disease","volume":"113","author":"Park","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2026012114162367500_ehf214073-bib-0011","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijcard.2016.05.031","article-title":"Clinical utility of natriuretic peptides and troponins in hypertrophic cardiomyopathy","volume":"218","author":"Kehl","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012114162367500_ehf214073-bib-0012","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/eurheartj\/ehn538","article-title":"Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis","volume":"30","author":"Cambronero","year":"2009","journal-title":"Eur Heart J"},{"key":"2026012114162367500_ehf214073-bib-0013","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"2026012114162367500_ehf214073-bib-0014","first-page":"557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical research ed)"},{"key":"2026012114162367500_ehf214073-bib-0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ (Clinical research ed)"},{"key":"2026012114162367500_ehf214073-bib-0016","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026012114162367500_ehf214073-bib-0017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamacardio.2017.4987","article-title":"Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction","volume":"3","author":"de Boer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026012114162367500_ehf214073-bib-0018","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006541","article-title":"Comparison of BNP and NT-proBNP in patients with heart failure and reduced ejection fraction","volume":"13","author":"R\u00f8rth","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2026012114162367500_ehf214073-bib-0019","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10554-011-9876-4","article-title":"Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging","volume":"28","author":"Park","year":"2012","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026012114162367500_ehf214073-bib-0020","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"2026012114162367500_ehf214073-bib-0021","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cardfail.2008.10.030","article-title":"Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review","volume":"15","author":"Ara\u00fajo","year":"2009","journal-title":"J Card Fail"},{"key":"2026012114162367500_ehf214073-bib-0022","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijcard.2018.02.027","article-title":"The prognostic value of high sensitivity C-reactive protein in a multi-ethnic population after &gt;10 years of follow-up: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"264","author":"Cainzos-Achirica","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026012114162367500_ehf214073-bib-0023","first-page":"1007","article-title":"Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"98","author":"Kuusisto","year":"2012","journal-title":"Heart (British Cardiac Society)"},{"key":"2026012114162367500_ehf214073-bib-0024","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.imbio.2012.01.008","article-title":"Monocytes as a diagnostic marker of cardiovascular diseases","volume":"217","author":"Gratchev","year":"2012","journal-title":"Immunobiology"},{"key":"2026012114162367500_ehf214073-bib-0025","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amjcard.2018.04.020","article-title":"Prediction of extensive myocardial fibrosis in nonhigh risk patients with hypertrophic cardiomyopathy","volume":"122","author":"Gommans","year":"2018","journal-title":"Am J Cardiol"},{"key":"2026012114162367500_ehf214073-bib-0026","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","article-title":"The molecular physiology of uric acid homeostasis","volume":"77","author":"Mandal","year":"2015","journal-title":"Annu Rev Physiol"},{"key":"2026012114162367500_ehf214073-bib-0027","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/eurjhf\/hft132","article-title":"Uric acid and risk of heart failure: a systematic review and meta-analysis","volume":"16","author":"Huang","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026012114162367500_ehf214073-bib-0028","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/01.CIR.0000066420.36123.35","article-title":"Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology","volume":"107","author":"Hare","year":"2003","journal-title":"Circulation"},{"key":"2026012114162367500_ehf214073-bib-0029","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"2026012114162367500_ehf214073-bib-0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ahj.2015.05.013","article-title":"Hypertrophic cardiomyopathy registry: the rationale and design of an international, observational study of hypertrophic cardiomyopathy","volume":"170","author":"Kramer","year":"2015","journal-title":"Am Heart J"},{"key":"2026012114162367500_ehf214073-bib-0031","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12471-021-01539-w","article-title":"BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants\u2014design and status","volume":"29","author":"Jansen","year":"2021","journal-title":"Neth Heart J"},{"key":"2026012114162367500_ehf214073-bib-0032","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12265-020-10051-2","article-title":"Difference in metabolomic response to exercise between patients with and without hypertrophic cardiomyopathy","volume":"14","author":"Shimada","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"key":"2026012114162367500_ehf214073-bib-0033","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007849","article-title":"Comprehensive proteomics profiling reveals circulating biomarkers of hypertrophic cardiomyopathy","volume":"14","author":"Shimada","year":"2021","journal-title":"Circ Heart Fail"},{"key":"2026012114162367500_ehf214073-bib-0034","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1074\/mcp.RA119.001586","article-title":"Identification of a multiplex biomarker panel for hypertrophic cardiomyopathy using quantitative proteomics and machine learning","volume":"19","author":"Captur","year":"2020","journal-title":"Mol Cell Proteom: MCP"},{"key":"2026012114162367500_ehf214073-bib-0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-80868-z","article-title":"Blood-based protein profiling identifies serum protein c-kit as a novel biomarker for hypertrophic cardiomyopathy","volume":"11","author":"Sonnenschein","year":"2021","journal-title":"Sci Rep"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.14073","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.14073","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/5\/3418\/65352545\/eschf_9_5_3418.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/5\/3418\/65352545\/eschf_9_5_3418.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:19:35Z","timestamp":1769023175000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/9\/5\/3418\/8323081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,17]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,7,17]]},"published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14073","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10]]},"published":{"date-parts":[[2022,7,17]]},"assertion":[{"value":"2022-03-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}